To further validate this Bax/Bak-independent apoptotic phenotype, we generated a Bax/Bak double-knockout (DKO) CLL cell line, MEC1, using a CRISPR/Cas9 system. Here, BAK1 is linked to B-cell chronic lymphocytic leukemia.